Search
for

    GlossaryTargeted Drug Delivery

    method of delivering medication directly to specific cells

    Targeted Drug Delivery, also known as Targeted Therapy, is a method of delivering medication directly to specific cells or tissues, minimizing exposure to healthy cells and reducing side effects. This approach is particularly useful in treating diseases like cancer, where drugs can be directed to attack only cancerous cells, thereby improving treatment efficacy and patient outcomes.

    Related Terms

    Learn

    5 / 801 results

      learn Dutasteride

      Heavy duty finasteride that comes with higher risks, but scalp injections seem safe and are gaining popularity

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

      learn Baricitinib

      JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp

    Research

    5 / 1000+ results

    Community Join

    5 / 146 results

      community Keratin microspheres - breakthrough

      in Research/Science  15 upvotes 2 years ago
      A gel of keratin microspheres promotes hair follicle growth, showing similar effectiveness to minoxidil in mice. The treatment activates hair growth pathways and reduces inflammation, with potential applications in drug delivery for hair-related disorders.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 1 year ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

      community Expectations control for SCUBE3

      in Research/Science  20 upvotes 2 years ago
      SCUBE3, a protein linked to hair growth in moles, was discovered over 25 years ago and is being developed by Amplifica for potential hair loss treatment. Concerns exist about SCUBE3's association with cancer, as it is a protein that promotes cell growth, which could potentially trigger cancer development if used for hair growth therapy.